Qualcomms AI Device Boom Drives Investor Enthusiasm
Morgan Stanley Highlights Potential Turnaround for Franklin Resources BEN
Wolfe Research Names Amazon AMZN a Top Pick in the Internet Sector
Chinas DeepSeek Challenges AI Cost Paradigm with LowChip Strategy
IFB Industries Q4 Net Profit Surges to Rs 4267 Crore Revenue Climbs 1233
RBIs Surprise Rate Cut Raises Questions on Policy Framework Nomura Says
MPLX Q1 2026 Earnings EPS Misses Estimates by 156 Amid Stable Distribution Outlook
Amplitech Group Inc AMPGZ Q1 2026 Earnings EPS Miss and Steep Stock Decline Highlight Ongoing Challenges
Builders FirstSource BLDR Q1 2026 Earnings EPS Misses Estimates Amid Market Challenges
Pineapple Financial Inc PAPL Q3 2025 Earnings Narrowing Losses Beat Expectations Yet Shares Slip
iHeartMedia IHRT Q1 2026 Earnings EPS Misses Estimates Stock Rallies Despite Loss
Via Transportation Inc VIA Q1 2026 Earnings EPS Beat Exceeds Estimates by 1319
TKO Group Holdings Inc TKO Holds Steady Near 190 as Traders Weigh Support and Resistance
Stereotaxis STXS Edges Higher Navigating the Robotics Sector with Modest Gains
Amylyx Pharmaceuticals AMLX Declines 25 as Stock Tests Key Support
SAIC SAIC Rallies 2 as Stock Holds Key Support Level
Weatherford International WFRD Holds Steady Near Support Amid Quiet Trading
SP 500 Inches Higher as Healthcare and Tech Lead Broad Gains
MWA Q1 2026 Earnings Earnings Per Share Beat Expectations Despite Modest Stock Decline
AutoZone AZO Slips 23 as Key Support Level Comes Into View
MHO Q1 2026 Earnings EPS Slightly Beats Estimate Stock Holds Steady
Revelation Biosciences Q1 2026 Earnings EPS Miss Highlights Ongoing PreRevenue Stage
CKX Lands Inc Q1 2025 Earnings Positive EPS Signals Operational Stability Amidst Revenue Uncertainty
GT Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment
Oxford Lane Capital Corp 625 Series 2027 Term Preferred Shares OXLCP Q4 2025 Earnings EPS Misses Estimates by 74 as Shares Edge Higher
Affinity Bancshares Q3 2023 Earnings Solid EPS Performance Amidst Modest Stock Reaction
ACTU Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Pipeline